nodes	percent_of_prediction	percent_of_DWPC	metapath
Vismodegib—SMO—glaucoma	0.6	1	CbGaD
Vismodegib—CYP2C19—Methazolamide—glaucoma	0.0234	0.113	CbGbCtD
Vismodegib—CYP2C9—Diclofenamide—glaucoma	0.0226	0.109	CbGbCtD
Vismodegib—CYP2C9—Dorzolamide—glaucoma	0.0218	0.105	CbGbCtD
Vismodegib—CYP2C19—Timolol—glaucoma	0.0199	0.0957	CbGbCtD
Vismodegib—CYP2C9—Methazolamide—glaucoma	0.0195	0.0935	CbGbCtD
Vismodegib—CYP3A4—Pilocarpine—glaucoma	0.0168	0.0805	CbGbCtD
Vismodegib—ABCB1—Timolol—glaucoma	0.0161	0.0772	CbGbCtD
Vismodegib—ABCB1—Clonidine—glaucoma	0.0137	0.0656	CbGbCtD
Vismodegib—CYP3A4—Brinzolamide—glaucoma	0.0132	0.0632	CbGbCtD
Vismodegib—CYP3A4—Dorzolamide—glaucoma	0.0127	0.061	CbGbCtD
Vismodegib—CYP3A4—Methazolamide—glaucoma	0.0113	0.0544	CbGbCtD
Vismodegib—CYP3A4—Acetazolamide—glaucoma	0.00905	0.0435	CbGbCtD
Vismodegib—CYP3A4—Clonidine—glaucoma	0.00818	0.0393	CbGbCtD
Vismodegib—Etoricoxib—PTGS2—glaucoma	0.000432	0.629	CrCbGaD
Vismodegib—Breast disorder—Clonidine—glaucoma	0.000373	0.00298	CcSEcCtD
Vismodegib—Dyspepsia—Methazolamide—glaucoma	0.000373	0.00298	CcSEcCtD
Vismodegib—Connective tissue disorder—Travoprost—glaucoma	0.00037	0.00296	CcSEcCtD
Vismodegib—Decreased appetite—Methazolamide—glaucoma	0.000368	0.00294	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Methazolamide—glaucoma	0.000365	0.00292	CcSEcCtD
Vismodegib—Connective tissue disorder—Brinzolamide—glaucoma	0.000365	0.00292	CcSEcCtD
Vismodegib—Fatigue—Methazolamide—glaucoma	0.000365	0.00292	CcSEcCtD
Vismodegib—Asthenia—Metipranolol—glaucoma	0.000362	0.0029	CcSEcCtD
Vismodegib—Abdominal pain—Carbachol—glaucoma	0.000355	0.00284	CcSEcCtD
Vismodegib—Dysgeusia—Acetazolamide—glaucoma	0.000352	0.00281	CcSEcCtD
Vismodegib—Pain—Latanoprost—glaucoma	0.00035	0.0028	CcSEcCtD
Vismodegib—Myalgia—Apraclonidine—glaucoma	0.000342	0.00273	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Apraclonidine—glaucoma	0.000339	0.00271	CcSEcCtD
Vismodegib—Dysgeusia—Brimonidine—glaucoma	0.000337	0.0027	CcSEcCtD
Vismodegib—Asthenia—Carteolol—glaucoma	0.000336	0.00268	CcSEcCtD
Vismodegib—Alopecia—Dorzolamide—glaucoma	0.000334	0.00267	CcSEcCtD
Vismodegib—Asthenia—Diclofenamide—glaucoma	0.00033	0.00264	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Bimatoprost—glaucoma	0.000329	0.00263	CcSEcCtD
Vismodegib—Alopecia—Brinzolamide—glaucoma	0.000328	0.00263	CcSEcCtD
Vismodegib—Hypokalaemia—Betaxolol—glaucoma	0.000327	0.00261	CcSEcCtD
Vismodegib—Pruritus—Diclofenamide—glaucoma	0.000325	0.0026	CcSEcCtD
Vismodegib—Breast disorder—Betaxolol—glaucoma	0.000324	0.00259	CcSEcCtD
Vismodegib—Malnutrition—Brinzolamide—glaucoma	0.000324	0.00259	CcSEcCtD
Vismodegib—Aspartate aminotransferase increased—Betaxolol—glaucoma	0.000323	0.00259	CcSEcCtD
Vismodegib—Dysgeusia—Dorzolamide—glaucoma	0.000322	0.00258	CcSEcCtD
Vismodegib—Nervous system disorder—Apraclonidine—glaucoma	0.000321	0.00257	CcSEcCtD
Vismodegib—Dysgeusia—Travoprost—glaucoma	0.000321	0.00257	CcSEcCtD
Vismodegib—Back pain—Dorzolamide—glaucoma	0.000318	0.00255	CcSEcCtD
Vismodegib—Rash—Metipranolol—glaucoma	0.000318	0.00255	CcSEcCtD
Vismodegib—Skin disorder—Apraclonidine—glaucoma	0.000318	0.00254	CcSEcCtD
Vismodegib—Dermatitis—Metipranolol—glaucoma	0.000318	0.00254	CcSEcCtD
Vismodegib—Asthenia—Levobunolol—glaucoma	0.000317	0.00254	CcSEcCtD
Vismodegib—Back pain—Travoprost—glaucoma	0.000317	0.00253	CcSEcCtD
Vismodegib—Dysgeusia—Brinzolamide—glaucoma	0.000317	0.00253	CcSEcCtD
Vismodegib—Alopecia—Pilocarpine—glaucoma	0.000316	0.00252	CcSEcCtD
Vismodegib—Back pain—Brinzolamide—glaucoma	0.000313	0.0025	CcSEcCtD
Vismodegib—Pruritus—Levobunolol—glaucoma	0.000313	0.0025	CcSEcCtD
Vismodegib—Nervous system disorder—Bimatoprost—glaucoma	0.000311	0.00249	CcSEcCtD
Vismodegib—Muscle spasms—Brinzolamide—glaucoma	0.000311	0.00249	CcSEcCtD
Vismodegib—Skin disorder—Bimatoprost—glaucoma	0.000309	0.00247	CcSEcCtD
Vismodegib—Diarrhoea—Carbachol—glaucoma	0.000307	0.00246	CcSEcCtD
Vismodegib—Dysgeusia—Pilocarpine—glaucoma	0.000305	0.00244	CcSEcCtD
Vismodegib—Asthenia—Methazolamide—glaucoma	0.000304	0.00243	CcSEcCtD
Vismodegib—Diarrhoea—Levobunolol—glaucoma	0.000302	0.00242	CcSEcCtD
Vismodegib—Back pain—Pilocarpine—glaucoma	0.000301	0.00241	CcSEcCtD
Vismodegib—Nausea—Metipranolol—glaucoma	0.0003	0.0024	CcSEcCtD
Vismodegib—Muscle spasms—Pilocarpine—glaucoma	0.000299	0.00239	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.000298	0.00239	CcSEcCtD
Vismodegib—Arthralgia—Brimonidine—glaucoma	0.000293	0.00235	CcSEcCtD
Vismodegib—Myalgia—Brimonidine—glaucoma	0.000293	0.00235	CcSEcCtD
Vismodegib—Pain in extremity—Timolol—glaucoma	0.000293	0.00235	CcSEcCtD
Vismodegib—Vomiting—Diclofenamide—glaucoma	0.000292	0.00234	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Brimonidine—glaucoma	0.000291	0.00233	CcSEcCtD
Vismodegib—Pruritus—Latanoprost—glaucoma	0.00029	0.00232	CcSEcCtD
Vismodegib—Rash—Diclofenamide—glaucoma	0.00029	0.00232	CcSEcCtD
Vismodegib—Diarrhoea—Methazolamide—glaucoma	0.00029	0.00232	CcSEcCtD
Vismodegib—Vomiting—Carbachol—glaucoma	0.000285	0.00228	CcSEcCtD
Vismodegib—Rash—Carbachol—glaucoma	0.000283	0.00226	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Apraclonidine—glaucoma	0.000283	0.00226	CcSEcCtD
Vismodegib—Dermatitis—Carbachol—glaucoma	0.000283	0.00226	CcSEcCtD
Vismodegib—Fatigue—Apraclonidine—glaucoma	0.000282	0.00226	CcSEcCtD
Vismodegib—Weight decreased—Betaxolol—glaucoma	0.000281	0.00224	CcSEcCtD
Vismodegib—Arthralgia—Dorzolamide—glaucoma	0.00028	0.00224	CcSEcCtD
Vismodegib—Pain—Apraclonidine—glaucoma	0.00028	0.00224	CcSEcCtD
Vismodegib—Constipation—Apraclonidine—glaucoma	0.00028	0.00224	CcSEcCtD
Vismodegib—Dyspepsia—Bimatoprost—glaucoma	0.00028	0.00224	CcSEcCtD
Vismodegib—Arthralgia—Travoprost—glaucoma	0.000279	0.00223	CcSEcCtD
Vismodegib—Myalgia—Travoprost—glaucoma	0.000279	0.00223	CcSEcCtD
Vismodegib—Nausea—Carteolol—glaucoma	0.000278	0.00222	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Travoprost—glaucoma	0.000277	0.00222	CcSEcCtD
Vismodegib—Nervous system disorder—Brimonidine—glaucoma	0.000276	0.00221	CcSEcCtD
Vismodegib—Myalgia—Brinzolamide—glaucoma	0.000275	0.0022	CcSEcCtD
Vismodegib—Arthralgia—Brinzolamide—glaucoma	0.000275	0.0022	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Bimatoprost—glaucoma	0.000274	0.00219	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Brinzolamide—glaucoma	0.000274	0.00219	CcSEcCtD
Vismodegib—Skin disorder—Brimonidine—glaucoma	0.000273	0.00218	CcSEcCtD
Vismodegib—Nausea—Diclofenamide—glaucoma	0.000273	0.00218	CcSEcCtD
Vismodegib—Pain—Bimatoprost—glaucoma	0.000272	0.00217	CcSEcCtD
Vismodegib—Vomiting—Methazolamide—glaucoma	0.000269	0.00215	CcSEcCtD
Vismodegib—Gastrointestinal pain—Apraclonidine—glaucoma	0.000268	0.00214	CcSEcCtD
Vismodegib—Abdominal pain upper—Timolol—glaucoma	0.000268	0.00214	CcSEcCtD
Vismodegib—Rash—Methazolamide—glaucoma	0.000267	0.00213	CcSEcCtD
Vismodegib—Dermatitis—Methazolamide—glaucoma	0.000267	0.00213	CcSEcCtD
Vismodegib—Nausea—Carbachol—glaucoma	0.000267	0.00213	CcSEcCtD
Vismodegib—Breast disorder—Timolol—glaucoma	0.000265	0.00212	CcSEcCtD
Vismodegib—Myalgia—Pilocarpine—glaucoma	0.000265	0.00212	CcSEcCtD
Vismodegib—Arthralgia—Pilocarpine—glaucoma	0.000265	0.00212	CcSEcCtD
Vismodegib—Nausea—Levobunolol—glaucoma	0.000262	0.0021	CcSEcCtD
Vismodegib—Nervous system disorder—Travoprost—glaucoma	0.000262	0.0021	CcSEcCtD
Vismodegib—Skin disorder—Travoprost—glaucoma	0.00026	0.00208	CcSEcCtD
Vismodegib—Abdominal pain—Apraclonidine—glaucoma	0.000259	0.00207	CcSEcCtD
Vismodegib—Nervous system disorder—Brinzolamide—glaucoma	0.000259	0.00207	CcSEcCtD
Vismodegib—Rash—Latanoprost—glaucoma	0.000258	0.00207	CcSEcCtD
Vismodegib—Dermatitis—Latanoprost—glaucoma	0.000258	0.00206	CcSEcCtD
Vismodegib—Dyspepsia—Acetazolamide—glaucoma	0.000258	0.00206	CcSEcCtD
Vismodegib—Skin disorder—Brinzolamide—glaucoma	0.000256	0.00205	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Brimonidine—glaucoma	0.000256	0.00205	CcSEcCtD
Vismodegib—Decreased appetite—Acetazolamide—glaucoma	0.000255	0.00204	CcSEcCtD
Vismodegib—Sulfasalazine—PTGS2—glaucoma	0.000254	0.371	CrCbGaD
Vismodegib—Gastrointestinal disorder—Acetazolamide—glaucoma	0.000253	0.00202	CcSEcCtD
Vismodegib—Fatigue—Acetazolamide—glaucoma	0.000253	0.00202	CcSEcCtD
Vismodegib—Alopecia—Clonidine—glaucoma	0.000252	0.00202	CcSEcCtD
Vismodegib—Nausea—Methazolamide—glaucoma	0.000251	0.00201	CcSEcCtD
Vismodegib—Dyspepsia—Brimonidine—glaucoma	0.000248	0.00198	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.000245	0.00196	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Travoprost—glaucoma	0.000244	0.00195	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Brimonidine—glaucoma	0.000243	0.00194	CcSEcCtD
Vismodegib—Fatigue—Brimonidine—glaucoma	0.000242	0.00194	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.000241	0.00192	CcSEcCtD
Vismodegib—Pain—Brimonidine—glaucoma	0.000241	0.00192	CcSEcCtD
Vismodegib—Muscle spasms—Clonidine—glaucoma	0.000239	0.00191	CcSEcCtD
Vismodegib—Dyspepsia—Dorzolamide—glaucoma	0.000236	0.00189	CcSEcCtD
Vismodegib—Dyspepsia—Travoprost—glaucoma	0.000235	0.00188	CcSEcCtD
Vismodegib—Asthenia—Apraclonidine—glaucoma	0.000235	0.00188	CcSEcCtD
Vismodegib—Decreased appetite—Dorzolamide—glaucoma	0.000233	0.00187	CcSEcCtD
Vismodegib—Dyspepsia—Brinzolamide—glaucoma	0.000232	0.00186	CcSEcCtD
Vismodegib—Pruritus—Apraclonidine—glaucoma	0.000232	0.00185	CcSEcCtD
Vismodegib—Fatigue—Dorzolamide—glaucoma	0.000232	0.00185	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.000231	0.00185	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Travoprost—glaucoma	0.000231	0.00185	CcSEcCtD
Vismodegib—Fatigue—Travoprost—glaucoma	0.000231	0.00184	CcSEcCtD
Vismodegib—Pain—Dorzolamide—glaucoma	0.00023	0.00184	CcSEcCtD
Vismodegib—Decreased appetite—Brinzolamide—glaucoma	0.00023	0.00184	CcSEcCtD
Vismodegib—Weight decreased—Timolol—glaucoma	0.000229	0.00183	CcSEcCtD
Vismodegib—Pain—Travoprost—glaucoma	0.000229	0.00183	CcSEcCtD
Vismodegib—Constipation—Travoprost—glaucoma	0.000229	0.00183	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Brinzolamide—glaucoma	0.000228	0.00182	CcSEcCtD
Vismodegib—Asthenia—Bimatoprost—glaucoma	0.000228	0.00182	CcSEcCtD
Vismodegib—Fatigue—Brinzolamide—glaucoma	0.000228	0.00182	CcSEcCtD
Vismodegib—Pain—Brinzolamide—glaucoma	0.000226	0.00181	CcSEcCtD
Vismodegib—Pruritus—Bimatoprost—glaucoma	0.000225	0.0018	CcSEcCtD
Vismodegib—Diarrhoea—Apraclonidine—glaucoma	0.000224	0.00179	CcSEcCtD
Vismodegib—Dyspepsia—Pilocarpine—glaucoma	0.000223	0.00179	CcSEcCtD
Vismodegib—Decreased appetite—Pilocarpine—glaucoma	0.000221	0.00176	CcSEcCtD
Vismodegib—Gastrointestinal pain—Dorzolamide—glaucoma	0.00022	0.00176	CcSEcCtD
Vismodegib—Alopecia—Betaxolol—glaucoma	0.000219	0.00175	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Pilocarpine—glaucoma	0.000219	0.00175	CcSEcCtD
Vismodegib—Gastrointestinal pain—Travoprost—glaucoma	0.000219	0.00175	CcSEcCtD
Vismodegib—Constipation—Pilocarpine—glaucoma	0.000217	0.00174	CcSEcCtD
Vismodegib—Pain—Pilocarpine—glaucoma	0.000217	0.00174	CcSEcCtD
Vismodegib—Malnutrition—Betaxolol—glaucoma	0.000216	0.00173	CcSEcCtD
Vismodegib—Abdominal pain—Dorzolamide—glaucoma	0.000212	0.0017	CcSEcCtD
Vismodegib—Dysgeusia—Betaxolol—glaucoma	0.000212	0.00169	CcSEcCtD
Vismodegib—Arthralgia—Clonidine—glaucoma	0.000211	0.00169	CcSEcCtD
Vismodegib—Abdominal pain—Travoprost—glaucoma	0.000211	0.00169	CcSEcCtD
Vismodegib—Asthenia—Acetazolamide—glaucoma	0.00021	0.00168	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Clonidine—glaucoma	0.00021	0.00168	CcSEcCtD
Vismodegib—Vomiting—Apraclonidine—glaucoma	0.000208	0.00167	CcSEcCtD
Vismodegib—Muscle spasms—Betaxolol—glaucoma	0.000208	0.00166	CcSEcCtD
Vismodegib—Gastrointestinal pain—Pilocarpine—glaucoma	0.000208	0.00166	CcSEcCtD
Vismodegib—Dermatitis—Apraclonidine—glaucoma	0.000206	0.00165	CcSEcCtD
Vismodegib—Asthenia—Brimonidine—glaucoma	0.000202	0.00161	CcSEcCtD
Vismodegib—Abdominal pain—Pilocarpine—glaucoma	0.000201	0.0016	CcSEcCtD
Vismodegib—Diarrhoea—Acetazolamide—glaucoma	0.0002	0.0016	CcSEcCtD
Vismodegib—Rash—Bimatoprost—glaucoma	0.0002	0.0016	CcSEcCtD
Vismodegib—Dermatitis—Bimatoprost—glaucoma	0.0002	0.0016	CcSEcCtD
Vismodegib—Connective tissue disorder—Timolol—glaucoma	0.000199	0.00159	CcSEcCtD
Vismodegib—Pruritus—Brimonidine—glaucoma	0.000199	0.00159	CcSEcCtD
Vismodegib—Nervous system disorder—Clonidine—glaucoma	0.000199	0.00159	CcSEcCtD
Vismodegib—Skin disorder—Clonidine—glaucoma	0.000197	0.00157	CcSEcCtD
Vismodegib—Nausea—Apraclonidine—glaucoma	0.000195	0.00156	CcSEcCtD
Vismodegib—Asthenia—Dorzolamide—glaucoma	0.000193	0.00154	CcSEcCtD
Vismodegib—Asthenia—Travoprost—glaucoma	0.000192	0.00153	CcSEcCtD
Vismodegib—Pruritus—Dorzolamide—glaucoma	0.00019	0.00152	CcSEcCtD
Vismodegib—Asthenia—Brinzolamide—glaucoma	0.000189	0.00151	CcSEcCtD
Vismodegib—Pruritus—Travoprost—glaucoma	0.000189	0.00151	CcSEcCtD
Vismodegib—Nausea—Bimatoprost—glaucoma	0.000189	0.00151	CcSEcCtD
Vismodegib—Pruritus—Brinzolamide—glaucoma	0.000187	0.00149	CcSEcCtD
Vismodegib—Vomiting—Acetazolamide—glaucoma	0.000186	0.00149	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Clonidine—glaucoma	0.000185	0.00148	CcSEcCtD
Vismodegib—Arthralgia—Betaxolol—glaucoma	0.000184	0.00147	CcSEcCtD
Vismodegib—Myalgia—Betaxolol—glaucoma	0.000184	0.00147	CcSEcCtD
Vismodegib—Diarrhoea—Dorzolamide—glaucoma	0.000184	0.00147	CcSEcCtD
Vismodegib—Diarrhoea—Travoprost—glaucoma	0.000183	0.00146	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Betaxolol—glaucoma	0.000183	0.00146	CcSEcCtD
Vismodegib—Asthenia—Pilocarpine—glaucoma	0.000182	0.00146	CcSEcCtD
Vismodegib—Diarrhoea—Brinzolamide—glaucoma	0.000181	0.00144	CcSEcCtD
Vismodegib—Pruritus—Pilocarpine—glaucoma	0.00018	0.00144	CcSEcCtD
Vismodegib—Alopecia—Timolol—glaucoma	0.000179	0.00143	CcSEcCtD
Vismodegib—Rash—Brimonidine—glaucoma	0.000177	0.00142	CcSEcCtD
Vismodegib—Dermatitis—Brimonidine—glaucoma	0.000177	0.00142	CcSEcCtD
Vismodegib—Malnutrition—Timolol—glaucoma	0.000177	0.00141	CcSEcCtD
Vismodegib—Decreased appetite—Clonidine—glaucoma	0.000176	0.00141	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Clonidine—glaucoma	0.000175	0.0014	CcSEcCtD
Vismodegib—Fatigue—Clonidine—glaucoma	0.000175	0.0014	CcSEcCtD
Vismodegib—Nausea—Acetazolamide—glaucoma	0.000174	0.00139	CcSEcCtD
Vismodegib—Diarrhoea—Pilocarpine—glaucoma	0.000174	0.00139	CcSEcCtD
Vismodegib—Pain—Clonidine—glaucoma	0.000173	0.00139	CcSEcCtD
Vismodegib—Constipation—Clonidine—glaucoma	0.000173	0.00139	CcSEcCtD
Vismodegib—Nervous system disorder—Betaxolol—glaucoma	0.000173	0.00138	CcSEcCtD
Vismodegib—Dysgeusia—Timolol—glaucoma	0.000173	0.00138	CcSEcCtD
Vismodegib—Skin disorder—Betaxolol—glaucoma	0.000171	0.00137	CcSEcCtD
Vismodegib—Vomiting—Dorzolamide—glaucoma	0.000171	0.00137	CcSEcCtD
Vismodegib—Rash—Dorzolamide—glaucoma	0.000169	0.00135	CcSEcCtD
Vismodegib—Dermatitis—Dorzolamide—glaucoma	0.000169	0.00135	CcSEcCtD
Vismodegib—Rash—Travoprost—glaucoma	0.000169	0.00135	CcSEcCtD
Vismodegib—Dermatitis—Travoprost—glaucoma	0.000168	0.00135	CcSEcCtD
Vismodegib—Vomiting—Brinzolamide—glaucoma	0.000168	0.00134	CcSEcCtD
Vismodegib—Nausea—Brimonidine—glaucoma	0.000167	0.00134	CcSEcCtD
Vismodegib—Rash—Brinzolamide—glaucoma	0.000166	0.00133	CcSEcCtD
Vismodegib—Dermatitis—Brinzolamide—glaucoma	0.000166	0.00133	CcSEcCtD
Vismodegib—Gastrointestinal pain—Clonidine—glaucoma	0.000166	0.00133	CcSEcCtD
Vismodegib—Vomiting—Pilocarpine—glaucoma	0.000161	0.00129	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000161	0.00129	CcSEcCtD
Vismodegib—Abdominal pain—Clonidine—glaucoma	0.00016	0.00128	CcSEcCtD
Vismodegib—Rash—Pilocarpine—glaucoma	0.00016	0.00128	CcSEcCtD
Vismodegib—Dermatitis—Pilocarpine—glaucoma	0.00016	0.00128	CcSEcCtD
Vismodegib—Nausea—Dorzolamide—glaucoma	0.00016	0.00128	CcSEcCtD
Vismodegib—Nausea—Travoprost—glaucoma	0.000159	0.00127	CcSEcCtD
Vismodegib—Nausea—Brinzolamide—glaucoma	0.000157	0.00125	CcSEcCtD
Vismodegib—Dyspepsia—Betaxolol—glaucoma	0.000155	0.00124	CcSEcCtD
Vismodegib—Decreased appetite—Betaxolol—glaucoma	0.000153	0.00123	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Betaxolol—glaucoma	0.000152	0.00122	CcSEcCtD
Vismodegib—Fatigue—Betaxolol—glaucoma	0.000152	0.00122	CcSEcCtD
Vismodegib—Pain—Betaxolol—glaucoma	0.000151	0.00121	CcSEcCtD
Vismodegib—Constipation—Betaxolol—glaucoma	0.000151	0.00121	CcSEcCtD
Vismodegib—Nausea—Pilocarpine—glaucoma	0.000151	0.00121	CcSEcCtD
Vismodegib—Myalgia—Timolol—glaucoma	0.00015	0.0012	CcSEcCtD
Vismodegib—Arthralgia—Timolol—glaucoma	0.00015	0.0012	CcSEcCtD
Vismodegib—Unspecified disorder of skin and subcutaneous tissue—Timolol—glaucoma	0.000149	0.00119	CcSEcCtD
Vismodegib—Asthenia—Clonidine—glaucoma	0.000145	0.00116	CcSEcCtD
Vismodegib—Pruritus—Clonidine—glaucoma	0.000143	0.00115	CcSEcCtD
Vismodegib—Nervous system disorder—Timolol—glaucoma	0.000141	0.00113	CcSEcCtD
Vismodegib—Skin disorder—Timolol—glaucoma	0.00014	0.00112	CcSEcCtD
Vismodegib—Diarrhoea—Clonidine—glaucoma	0.000139	0.00111	CcSEcCtD
Vismodegib—Musculoskeletal discomfort—Timolol—glaucoma	0.000131	0.00105	CcSEcCtD
Vismodegib—Vomiting—Clonidine—glaucoma	0.000129	0.00103	CcSEcCtD
Vismodegib—Rash—Clonidine—glaucoma	0.000128	0.00102	CcSEcCtD
Vismodegib—Dermatitis—Clonidine—glaucoma	0.000128	0.00102	CcSEcCtD
Vismodegib—Dyspepsia—Timolol—glaucoma	0.000127	0.00101	CcSEcCtD
Vismodegib—Asthenia—Betaxolol—glaucoma	0.000127	0.00101	CcSEcCtD
Vismodegib—Decreased appetite—Timolol—glaucoma	0.000125	0.001	CcSEcCtD
Vismodegib—Pruritus—Betaxolol—glaucoma	0.000125	0.000998	CcSEcCtD
Vismodegib—Gastrointestinal disorder—Timolol—glaucoma	0.000124	0.000995	CcSEcCtD
Vismodegib—Fatigue—Timolol—glaucoma	0.000124	0.000994	CcSEcCtD
Vismodegib—Pain—Timolol—glaucoma	0.000123	0.000986	CcSEcCtD
Vismodegib—Diarrhoea—Betaxolol—glaucoma	0.000121	0.000965	CcSEcCtD
Vismodegib—Nausea—Clonidine—glaucoma	0.00012	0.000963	CcSEcCtD
Vismodegib—Gastrointestinal pain—Timolol—glaucoma	0.000118	0.000943	CcSEcCtD
Vismodegib—Abdominal pain—Timolol—glaucoma	0.000114	0.000911	CcSEcCtD
Vismodegib—Vomiting—Betaxolol—glaucoma	0.000112	0.000897	CcSEcCtD
Vismodegib—Rash—Betaxolol—glaucoma	0.000111	0.00089	CcSEcCtD
Vismodegib—Dermatitis—Betaxolol—glaucoma	0.000111	0.000889	CcSEcCtD
Vismodegib—Nausea—Betaxolol—glaucoma	0.000105	0.000838	CcSEcCtD
Vismodegib—Asthenia—Timolol—glaucoma	0.000103	0.000827	CcSEcCtD
Vismodegib—Pruritus—Timolol—glaucoma	0.000102	0.000816	CcSEcCtD
Vismodegib—Diarrhoea—Timolol—glaucoma	9.86e-05	0.000789	CcSEcCtD
Vismodegib—Vomiting—Timolol—glaucoma	9.17e-05	0.000733	CcSEcCtD
Vismodegib—Rash—Timolol—glaucoma	9.09e-05	0.000727	CcSEcCtD
Vismodegib—Dermatitis—Timolol—glaucoma	9.08e-05	0.000726	CcSEcCtD
Vismodegib—Nausea—Timolol—glaucoma	8.56e-05	0.000685	CcSEcCtD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC6A13—glaucoma	6.54e-05	0.000988	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—PEX19—glaucoma	6.46e-05	0.000976	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—EDN1—glaucoma	6.15e-05	0.00093	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—IL1A—glaucoma	6.06e-05	0.000916	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—EDN1—glaucoma	5.83e-05	0.000882	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTT1—glaucoma	5.83e-05	0.000881	CbGpPWpGaD
Vismodegib—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	5.79e-05	0.000875	CbGpPWpGaD
Vismodegib—ABCG2—HIF-1-alpha transcription factor network—VEGFA—glaucoma	5.71e-05	0.000864	CbGpPWpGaD
Vismodegib—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	5.71e-05	0.000863	CbGpPWpGaD
Vismodegib—CYP2C8—Arachidonic acid metabolism—PTGS2—glaucoma	5.62e-05	0.00085	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—MTHFR—glaucoma	5.57e-05	0.000843	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—SMO—glaucoma	5.51e-05	0.000834	CbGpPWpGaD
Vismodegib—SHH—Disease—CDKN2B—glaucoma	5.41e-05	0.000818	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—FAS—glaucoma	5.4e-05	0.000817	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC6A13—glaucoma	5.38e-05	0.000814	CbGpPWpGaD
Vismodegib—SHH—Signaling by GPCR—C3—glaucoma	5.38e-05	0.000813	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—C3—glaucoma	5.32e-05	0.000805	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—FN1—glaucoma	5.28e-05	0.000799	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTT1—glaucoma	5.2e-05	0.000786	CbGpPWpGaD
Vismodegib—SMO—Signaling by GPCR—C3—glaucoma	5.1e-05	0.00077	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NTRK2—glaucoma	5.04e-05	0.000762	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—FN1—glaucoma	5.03e-05	0.000761	CbGpPWpGaD
Vismodegib—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	5.02e-05	0.000759	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.98e-05	0.000753	CbGpPWpGaD
Vismodegib—ALB—SLC-mediated transmembrane transport—SLC6A1—glaucoma	4.78e-05	0.000723	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NTRK2—glaucoma	4.78e-05	0.000723	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTT1—glaucoma	4.74e-05	0.000717	CbGpPWpGaD
Vismodegib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—glaucoma	4.71e-05	0.000713	CbGpPWpGaD
Vismodegib—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	4.69e-05	0.000709	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—CYP1B1—glaucoma	4.64e-05	0.000702	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—CYP1B1—glaucoma	4.58e-05	0.000692	CbGpPWpGaD
Vismodegib—CYP2C9—Arachidonic acid metabolism—PTGS2—glaucoma	4.57e-05	0.000692	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—glaucoma	4.56e-05	0.00069	CbGpPWpGaD
Vismodegib—SHH—Disease—MTHFR—glaucoma	4.53e-05	0.000686	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—TGFB2—glaucoma	4.44e-05	0.000672	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC4A4—glaucoma	4.36e-05	0.00066	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.34e-05	0.000656	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NGFR—glaucoma	4.33e-05	0.000654	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CTSA—glaucoma	4.31e-05	0.000652	CbGpPWpGaD
Vismodegib—SHH—Disease—APOE—glaucoma	4.22e-05	0.000638	CbGpPWpGaD
Vismodegib—SHH—Disease—CAV1—glaucoma	4.18e-05	0.000632	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—CYP1B1—glaucoma	4.14e-05	0.000626	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NTRK1—glaucoma	4.11e-05	0.000621	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NGFR—glaucoma	4.1e-05	0.00062	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	4.09e-05	0.000618	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NARFL—glaucoma	4.08e-05	0.000617	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA5A—glaucoma	4.08e-05	0.000617	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NARFL—glaucoma	4.06e-05	0.000614	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA5A—glaucoma	4.06e-05	0.000614	CbGpPWpGaD
Vismodegib—ABCG2—Transmembrane transport of small molecules—SLC6A1—glaucoma	3.94e-05	0.000596	CbGpPWpGaD
Vismodegib—SHH—Disease—BAD—glaucoma	3.93e-05	0.000595	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NTRK1—glaucoma	3.9e-05	0.000589	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.87e-05	0.000585	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CDKN2B—glaucoma	3.79e-05	0.000573	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—CYP1B1—glaucoma	3.78e-05	0.000571	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—CYP1B1—glaucoma	3.73e-05	0.000563	CbGpPWpGaD
Vismodegib—ALB—Vitamin B12 Metabolism—TNF—glaucoma	3.71e-05	0.000562	CbGpPWpGaD
Vismodegib—CYP2C8—Biological oxidations—GSTM1—glaucoma	3.71e-05	0.000561	CbGpPWpGaD
Vismodegib—CYP2C8—Metapathway biotransformation—GSTM1—glaucoma	3.66e-05	0.000553	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA5A—glaucoma	3.64e-05	0.000551	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NARFL—glaucoma	3.64e-05	0.000551	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—EDN1—glaucoma	3.63e-05	0.00055	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CDKN2B—glaucoma	3.59e-05	0.000543	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NARFL—glaucoma	3.56e-05	0.000538	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA5A—glaucoma	3.56e-05	0.000538	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—PTGS2—glaucoma	3.56e-05	0.000538	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CTSA—glaucoma	3.53e-05	0.000534	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—EDN1—glaucoma	3.45e-05	0.000521	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—glaucoma	3.4e-05	0.000514	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—SOD1—glaucoma	3.37e-05	0.000509	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NGF—glaucoma	3.34e-05	0.000505	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA5A—glaucoma	3.32e-05	0.000502	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NARFL—glaucoma	3.32e-05	0.000502	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC6A13—glaucoma	3.32e-05	0.000502	CbGpPWpGaD
Vismodegib—CYP2C19—Biological oxidations—GSTM1—glaucoma	3.31e-05	0.000501	CbGpPWpGaD
Vismodegib—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	3.27e-05	0.000494	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CA1—glaucoma	3.21e-05	0.000486	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—C3—glaucoma	3.18e-05	0.00048	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NGF—glaucoma	3.17e-05	0.000479	CbGpPWpGaD
Vismodegib—SHH—Disease—NOS3—glaucoma	3.16e-05	0.000478	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—glaucoma	3.13e-05	0.000474	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTT1—glaucoma	3.13e-05	0.000473	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—glaucoma	3.11e-05	0.000471	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CTSA—glaucoma	3.11e-05	0.00047	CbGpPWpGaD
Vismodegib—ABCB1—HIF-1-alpha transcription factor network—VEGFA—glaucoma	3.09e-05	0.000467	CbGpPWpGaD
Vismodegib—ALB—Platelet degranulation—VEGFA—glaucoma	3.02e-05	0.000457	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TNF—glaucoma	3.02e-05	0.000457	CbGpPWpGaD
Vismodegib—CYP2C9—Biological oxidations—GSTM1—glaucoma	3.02e-05	0.000457	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—C3—glaucoma	3.01e-05	0.000455	CbGpPWpGaD
Vismodegib—CYP2C9—Metapathway biotransformation—GSTM1—glaucoma	2.98e-05	0.00045	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—APOE—glaucoma	2.96e-05	0.000447	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CA2—glaucoma	2.94e-05	0.000444	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CAV1—glaucoma	2.93e-05	0.000443	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC6A13—glaucoma	2.91e-05	0.00044	CbGpPWpGaD
Vismodegib—SHH—Disease—PTGS2—glaucoma	2.89e-05	0.000437	CbGpPWpGaD
Vismodegib—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—glaucoma	2.88e-05	0.000435	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—APOE—glaucoma	2.8e-05	0.000424	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—FN1—glaucoma	2.79e-05	0.000421	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CAV1—glaucoma	2.78e-05	0.00042	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—BAD—glaucoma	2.75e-05	0.000416	CbGpPWpGaD
Vismodegib—SHH—Disease—CDKN1B—glaucoma	2.74e-05	0.000414	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—VEGFA—glaucoma	2.68e-05	0.000404	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—glaucoma	2.67e-05	0.000403	CbGpPWpGaD
Vismodegib—ALB—Folate Metabolism—TP53—glaucoma	2.66e-05	0.000403	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—FN1—glaucoma	2.64e-05	0.0004	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—BAD—glaucoma	2.61e-05	0.000395	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—CYP1B1—glaucoma	2.49e-05	0.000377	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	2.46e-05	0.000372	CbGpPWpGaD
Vismodegib—ALB—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.43e-05	0.000368	CbGpPWpGaD
Vismodegib—ALB—Selenium Micronutrient Network—TNF—glaucoma	2.4e-05	0.000363	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—FN1—glaucoma	2.34e-05	0.000354	CbGpPWpGaD
Vismodegib—ABCB1—Allograft Rejection—TNF—glaucoma	2.29e-05	0.000347	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TGFB2—glaucoma	2.29e-05	0.000346	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—glaucoma	2.28e-05	0.000345	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—NOS3—glaucoma	2.21e-05	0.000335	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA5A—glaucoma	2.19e-05	0.000331	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NARFL—glaucoma	2.19e-05	0.000331	CbGpPWpGaD
Vismodegib—ABCB1—Transmembrane transport of small molecules—SLC6A1—glaucoma	2.13e-05	0.000322	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—NOS3—glaucoma	2.1e-05	0.000317	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—TXN—glaucoma	2.07e-05	0.000313	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA1—glaucoma	1.99e-05	0.000301	CbGpPWpGaD
Vismodegib—CYP3A4—Biological oxidations—GSTM1—glaucoma	1.99e-05	0.000301	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA1—glaucoma	1.98e-05	0.0003	CbGpPWpGaD
Vismodegib—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	1.96e-05	0.000297	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CTSA—glaucoma	1.93e-05	0.000292	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CTSA—glaucoma	1.92e-05	0.00029	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—CDKN1B—glaucoma	1.92e-05	0.00029	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CA2—glaucoma	1.82e-05	0.000276	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—CDKN1B—glaucoma	1.82e-05	0.000275	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CA2—glaucoma	1.81e-05	0.000274	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.78e-05	0.00027	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.78e-05	0.00027	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA1—glaucoma	1.78e-05	0.000269	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—MMP9—glaucoma	1.78e-05	0.000269	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.77e-05	0.000268	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.77e-05	0.000268	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA1—glaucoma	1.74e-05	0.000263	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—SOD1—glaucoma	1.74e-05	0.000262	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CTSA—glaucoma	1.72e-05	0.000261	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—MMP9—glaucoma	1.68e-05	0.000255	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CTSA—glaucoma	1.68e-05	0.000254	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—glaucoma	1.68e-05	0.000253	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CA2—glaucoma	1.63e-05	0.000246	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA1—glaucoma	1.62e-05	0.000245	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTT1—glaucoma	1.61e-05	0.000243	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—VEGFA—glaucoma	1.6e-05	0.000241	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.59e-05	0.000241	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.59e-05	0.000241	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CA2—glaucoma	1.59e-05	0.00024	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—glaucoma	1.59e-05	0.00024	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CTSA—glaucoma	1.57e-05	0.000238	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—VEGFA—glaucoma	1.51e-05	0.000229	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CA2—glaucoma	1.48e-05	0.000224	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	1.45e-05	0.000219	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	1.45e-05	0.000219	CbGpPWpGaD
Vismodegib—ALB—Platelet activation, signaling and aggregation—VEGFA—glaucoma	1.34e-05	0.000203	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—MMP1—glaucoma	1.32e-05	0.0002	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—glaucoma	1.32e-05	0.0002	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—TXN—glaucoma	1.28e-05	0.000194	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—ABCA1—glaucoma	1.28e-05	0.000193	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CYP1B1—glaucoma	1.28e-05	0.000193	CbGpPWpGaD
Vismodegib—ALB—Metabolism—TXN—glaucoma	1.28e-05	0.000193	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—CAV1—glaucoma	1.27e-05	0.000192	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—FN1—glaucoma	1.21e-05	0.000183	CbGpPWpGaD
Vismodegib—SHH—Signaling Pathways—TP53—glaucoma	1.21e-05	0.000182	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.17e-05	0.000177	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.17e-05	0.000176	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.16e-05	0.000176	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.16e-05	0.000175	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—TXN—glaucoma	1.15e-05	0.000173	CbGpPWpGaD
Vismodegib—SMO—Signaling Pathways—TP53—glaucoma	1.14e-05	0.000173	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—glaucoma	1.13e-05	0.000171	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—TXN—glaucoma	1.12e-05	0.000169	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA1—glaucoma	1.07e-05	0.000162	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	1.05e-05	0.000158	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—TXN—glaucoma	1.05e-05	0.000158	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	1.04e-05	0.000157	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CTSA—glaucoma	1.04e-05	0.000157	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—GSTM1—glaucoma	1.02e-05	0.000155	CbGpPWpGaD
Vismodegib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—glaucoma	9.98e-06	0.000151	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTT1—glaucoma	9.96e-06	0.000151	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTT1—glaucoma	9.91e-06	0.00015	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CA2—glaucoma	9.79e-06	0.000148	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—NOS3—glaucoma	9.59e-06	0.000145	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—glaucoma	9.54e-06	0.000144	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—glaucoma	9.45e-06	0.000143	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—MTHFR—glaucoma	9.04e-06	0.000137	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTT1—glaucoma	8.89e-06	0.000134	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTT1—glaucoma	8.68e-06	0.000131	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—APOE—glaucoma	8.41e-06	0.000127	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—CAV1—glaucoma	8.34e-06	0.000126	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTT1—glaucoma	8.11e-06	0.000123	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	8.03e-06	0.000121	CbGpPWpGaD
Vismodegib—ALB—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.99e-06	0.000121	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—ABCA1—glaucoma	7.94e-06	0.00012	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CYP1B1—glaucoma	7.94e-06	0.00012	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CYP1B1—glaucoma	7.89e-06	0.000119	CbGpPWpGaD
Vismodegib—ALB—Metabolism—ABCA1—glaucoma	7.89e-06	0.000119	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	7.17e-06	0.000108	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CYP1B1—glaucoma	7.09e-06	0.000107	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—ABCA1—glaucoma	7.09e-06	0.000107	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—ABCA1—glaucoma	6.92e-06	0.000105	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CYP1B1—glaucoma	6.92e-06	0.000105	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—VEGFA—glaucoma	6.91e-06	0.000104	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—TXN—glaucoma	6.9e-06	0.000104	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	6.54e-06	9.89e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—ABCA1—glaucoma	6.46e-06	9.77e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CYP1B1—glaucoma	6.46e-06	9.77e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—GSTM1—glaucoma	6.35e-06	9.59e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—GSTM1—glaucoma	6.31e-06	9.54e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—NOS3—glaucoma	6.3e-06	9.53e-05	CbGpPWpGaD
Vismodegib—ABCG2—Metabolism—PTGS2—glaucoma	5.77e-06	8.72e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—GSTM1—glaucoma	5.66e-06	8.56e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—MTHFR—glaucoma	5.61e-06	8.48e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—MTHFR—glaucoma	5.58e-06	8.43e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—GSTM1—glaucoma	5.53e-06	8.36e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTT1—glaucoma	5.35e-06	8.09e-05	CbGpPWpGaD
Vismodegib—ALB—Hemostasis—TP53—glaucoma	5.22e-06	7.9e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—APOE—glaucoma	5.22e-06	7.89e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—APOE—glaucoma	5.19e-06	7.85e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—CAV1—glaucoma	5.17e-06	7.82e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—GSTM1—glaucoma	5.17e-06	7.81e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—CAV1—glaucoma	5.14e-06	7.78e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—MTHFR—glaucoma	5.01e-06	7.57e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—MTHFR—glaucoma	4.89e-06	7.39e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—APOE—glaucoma	4.66e-06	7.05e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—CAV1—glaucoma	4.62e-06	6.98e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—MTHFR—glaucoma	4.56e-06	6.9e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—APOE—glaucoma	4.55e-06	6.88e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—CAV1—glaucoma	4.51e-06	6.81e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—ABCA1—glaucoma	4.26e-06	6.44e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CYP1B1—glaucoma	4.26e-06	6.44e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—APOE—glaucoma	4.25e-06	6.43e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—CAV1—glaucoma	4.21e-06	6.37e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—NOS3—glaucoma	3.91e-06	5.91e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—NOS3—glaucoma	3.89e-06	5.88e-05	CbGpPWpGaD
Vismodegib—CYP2C8—Metabolism—PTGS2—glaucoma	3.58e-06	5.41e-05	CbGpPWpGaD
Vismodegib—ALB—Metabolism—PTGS2—glaucoma	3.56e-06	5.38e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—NOS3—glaucoma	3.49e-06	5.28e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—NOS3—glaucoma	3.41e-06	5.15e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—GSTM1—glaucoma	3.41e-06	5.15e-05	CbGpPWpGaD
Vismodegib—CYP2C19—Metabolism—PTGS2—glaucoma	3.19e-06	4.83e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—NOS3—glaucoma	3.18e-06	4.81e-05	CbGpPWpGaD
Vismodegib—ABCB1—Metabolism—PTGS2—glaucoma	3.12e-06	4.71e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—MTHFR—glaucoma	3.01e-06	4.55e-05	CbGpPWpGaD
Vismodegib—CYP2C9—Metabolism—PTGS2—glaucoma	2.91e-06	4.4e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—APOE—glaucoma	2.8e-06	4.24e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—CAV1—glaucoma	2.78e-06	4.2e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—NOS3—glaucoma	2.1e-06	3.17e-05	CbGpPWpGaD
Vismodegib—CYP3A4—Metabolism—PTGS2—glaucoma	1.92e-06	2.9e-05	CbGpPWpGaD
